PD-L1 ANTAGONIST COMPOUND - ADLAI NORTYE BIOPHARMA CO LTD

Title:

PD-L1 ANTAGONIST COMPOUND

Document Type and Number:

WIPO Patent Application WO/2021/129584

Kind Code:

A1

Abstract:

Provided are a compound of formula (I) and a pharmaceutical composition thereof, as well as a method for using the compound of formula (I) to prevent and/or treat immune-related disorders.

More Like This:

WO/1995/000507	AZOLYL-CYCLIC AMINE DERIVATIVES WITH IMMUNOMODULATORY ACTIVITY
WO/1999/031074	((CYCLO)ALKYL SUBSTITUTED)-.GAMMA.-AMINOBUTYRIC ACID DERIVATIVES (=GABA ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

Inventors:

YU ZHIYONG (CN)
LI PAN (CN)
XU BEIDI (CN)
ZHOU YU (CN)
PANG WEI (CN)
WEN QIAODONG (CN)
SHI YONGQIANG (CN)
SUN ZHAO (CN)
LV MENG (CN)

Application Number:

PCT/CN2020/138157

Publication Date:

July 01, 2021

Filing Date:

December 22, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ADLAI NORTYE BIOPHARMA CO LTD (CN)

International Classes:

A61K31/4427; C07D401/14; A61P37/02; C07D401/02; C07D401/06

Domestic Patent References:

WO2020169058A1	2020-08-27
WO2018195321A1	2018-10-25

Foreign References:

CN109665968A	2019-04-23
CN109689640A	2019-04-26
CN105705489A	2016-06-22
CN106536515A	2017-03-22

Other References:

ALLEN L.V.JR. ET AL.: "Remington: The Science and Practice of Pharmacy", vol. 2, 2012, PHARMACEUTICAL PRESS
See also references of EP 4083032A4

Attorney, Agent or Firm:

UNITALEN ATTORNEYS AT LAW (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: POLYMER ELECTROLYTE, AND LITHIUM ION BATTERY COMPRISING SAME

Next Patent: METHOD AND SYSTEM FOR PROVIDING LOCATION POINT RECOMMENDATION FOR USER